[1]
Tsai, H.-H.D. et al. 2024. Risk-based prioritization of PFAS using phenotypic and transcriptomic data from human induced pluripotent stem cell-derived hepatocytes and cardiomyocytes. ALTEX - Alternatives to animal experimentation. 41, 3 (Jul. 2024), 363–381. DOI:https://doi.org/10.14573/altex.2311031.